Filing Details
- Accession Number:
- 0001209191-19-049474
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-13 16:13:43
- Reporting Period:
- 2019-09-12
- Accepted Time:
- 2019-09-13 16:13:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
917520 | Integra Lifesciences Holdings Corp | IART | Surgical & Medical Instruments & Apparatus (3841) | 510317849 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1563593 | John Mooradian | 311 C Enterprise Drive Plainsboro NJ 08536 | Corp Vp, Global Ops & Supp Chn | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-09-12 | 3,296 | $26.87 | 18,706 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-09-12 | 3,296 | $62.53 | 15,410 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2019-09-12 | 609 | $56.23 | 16,019 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-09-12 | 609 | $62.53 | 15,410 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2019-09-12 | 1,681 | $43.68 | 17,091 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-09-12 | 1,681 | $62.53 | 15,410 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2019-09-12 | 3,663 | $32.59 | 19,073 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-09-12 | 3,663 | $62.53 | 15,410 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-09-12 | 3,296 | $0.00 | 3,296 | $26.87 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-09-12 | 3,663 | $0.00 | 3,663 | $32.59 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-09-12 | 1,681 | $0.00 | 1,681 | $43.68 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-09-12 | 609 | $0.00 | 609 | $56.23 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2023-03-23 | No | 4 | M | Direct | |
1,221 | 2024-03-14 | No | 4 | M | Direct | |
1,682 | 2025-03-13 | No | 4 | M | Direct | |
1,830 | 2026-03-13 | No | 4 | M | Direct |
Footnotes
- The price shown above represents the weighted average price of the shares sold. The range of sale prices was $62.17 to $63.
- 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 3/23/2015.
- This option was previously reported as covering 1,426 shares at an exercise price of $62.10 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015.
- In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to eflect the two-for-one stock split that occurred on December 21, 2016.
- 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 3/14/2016.
- 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 3/13/2017.
- 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 3/13/2018.